Verified

Pediatric Alopecia Areata Challenge Grant

Pediatric Dermatology Research Alliance

Alopecia areata (AA) is a common autoimmune skin disease that causes hair loss on the scalp, face, and sometimes on other areas of the body, affecting as many as 160 million people worldwide. Nearly half of patients experience their first episode of alopecia areata before age 20, highlighting the impact of the disease in children and adolescents. Recent clinical data indicate that treatment efficacy decreases with length of time living with severe disease, suggesting that early disease management is needed to prevent a lifetime without hair. Pediatric alopecia areata remains a critical target for research and therapeutic development. Currently, there is only one FDA-approved treatment for adolescents ages 12 and older, limiting effective treatment options for most pediatric patients. The burdens on AA patients and their families are significant and many key research questions remain unanswered.

To address this need, the National Alopecia Areata Foundation (NAAF) and the Pediatric Dermatology Research Alliance (PeDRA) are collaborating to support research investigations focused on pediatric alopecia areata with the Pediatric Alopecia Areata Challenge Grant. Through this grant, NAAF and PeDRA intend to accelerate research that improves the lives of pediatric alopecia areata patients and their families.

Focus

This Challenge Grant is intended to stimulate scientists to establish or sustain research programs focused on pediatric alopecia areata. Investigators with any innovative research idea are encouraged to apply, with priority consideration given to proposals that address one or more of the following areas of interest:

Investigations of targets or pathways that will advance understanding of the pathophysiology of pediatric AA
Investigations of epidemiology or the natural history of pediatric AA
Development of patient reported outcome measures specific to pediatric AA
Elucidation of the burden of pediatric alopecia areata on patients and families including the psychosocial impact
Advances in treatment or tools for treatment decision-making by patients and families

Priority consideration will be given to projects led by early-to-mid career principal investigators collaborating with senior mentors and projects that address high-priority research questions.

Important Details

Up to $75,000 to support one year of research
One award anticipated for this funding cycle
Application deadline: Thursday, September 17, 2026

AI Based Application Success Predictor

1. Direct relevance to pediatric dermatology (Highest Predictor ⭐⭐⭐⭐⭐)

This is the most important criterion.

Competitive proposals should focus on childhood skin diseases, such as:

Atopic dermatitis (eczema)
Pediatric psoriasis
Birthmarks and vascular anomalies
Ichthyosis
Epidermolysis bullosa
Pediatric hidradenitis suppurativa
Pigmentary disorders
Genetic skin diseases
Pediatric skin infections
Autoimmune skin disorders
Pediatric skin tumors

Projects outside pediatric dermatology are generally not competitive.

2. Innovation and early-stage research (Highest Predictor ⭐⭐⭐⭐⭐)

PeDRA specifically supports early-stage research projects where preliminary data may be limited.

Competitive proposals should include:

Novel hypotheses
Innovative methodologies
New diagnostic tools
Precision medicine
Translational science
Emerging technologies
Digital dermatology
AI-assisted dermatology
New therapeutic strategies

The goal is to generate new ideas that can lead to larger externally funded studies.

3. Strong potential to improve pediatric skin health (Highest Predictor ⭐⭐⭐⭐⭐)

Competitive projects should demonstrate potential to:

Improve diagnosis
Develop better treatments
Improve quality of life
Reduce disease burden
Improve long-term outcomes
Advance standards of care

Research with clear patient benefit receives strong consideration.

4. Scientific excellence and rigorous methodology (Highest Predictor ⭐⭐⭐⭐⭐)

Competitive applications include:

Clearly defined hypotheses
Robust study design
Appropriate statistical analysis
Feasible methodology
Clearly defined outcomes
Realistic milestones

Methodological rigor is essential for successful peer review.

5. Potential to generate preliminary data for larger grants (Very High Predictor ⭐⭐⭐⭐⭐)

A defining feature of PeDRA Research Grants is that they are intended to support projects that:

Generate pilot data
Build research infrastructure
Support future NIH or foundation applications
Lead to multicenter studies

Applications should explain how the project will position investigators for larger external funding.

6. Collaboration and multidisciplinary research (Very High Predictor ⭐⭐⭐⭐⭐)

PeDRA encourages collaboration among:

Pediatric dermatologists
Dermatologists
Pediatricians
Basic scientists
Geneticists
Immunologists
Epidemiologists
Biostatisticians
Patient advocacy organizations

Multi-institutional collaborations are welcomed and strengthen proposals.

7. Meaningful patient advocacy and community engagement (Very High Predictor ⭐⭐⭐⭐⭐)

One of PeDRA's distinctive priorities is patient engagement.

Priority consideration is given to projects that demonstrate:

Meaningful collaboration with patient advocacy groups
Sustained engagement with patients and families
Patient-centered research questions
Incorporation of patient perspectives throughout the project

This is explicitly highlighted in the Emerging Investigator Research Grants (EIRG) program.

8. Alignment with PeDRA Focused Study Groups and strategic priorities (High Predictor ⭐⭐⭐⭐☆)

Competitive proposals align with:

PeDRA Focused Study Groups
Existing research initiatives
Strategic research priorities
Disease-specific collaborative networks

Projects that fit ongoing PeDRA initiatives receive additional priority.

9. Early-career investigator development and mentorship (High Predictor ⭐⭐⭐⭐☆)

PeDRA places strong emphasis on developing future pediatric dermatology researchers.

Competitive applicants should demonstrate:

Strong mentorship
Career development potential
Commitment to pediatric dermatology research
Appropriate research training

Programs such as the Emerging Investigator Research Grants are specifically designed for medical students, pediatric residents, and recent graduates.

10. Feasible budget, dissemination, and compliance (High Predictor ⭐⭐⭐⭐☆)

Competitive proposals include:

Realistic budgets
Appropriate project timelines
Clear dissemination plans
Publication strategy
Compliance with PeDRA grant policies

Awardees are expected to acknowledge PeDRA support in publications and presentations, and indirect costs are generally not allowed.

Specialties

Dermatology

Pediatrics

Eligibility Requirements

Applicants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution. Principal Investigators need not be United States citizens and the research need not be conducted in the United States. Evidence of IRB or IACUC (or equivalent) approval is required for all studies when relevant. Recipients of past or current NAAF and/or PeDRA grants are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: Pediatric Dermatology Research Alliance

Sponsor Type: Corporate/Non-Profit

Address: 205 SE Spokane St., Suite 300 Portland, OR 97202

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity